| 2024/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | |
| Interest Income | 112,740 | -19.574% | 140,179 | 138,502 | 139,788 | 146,251 |
| Interest Expense | (438) | -45.247% | (800) | (2,904) | (2,094) | (2,706) |
| Net Interest Income | 112,302 | -19.427% | 139,379 | 135,598 | 137,694 | 143,545 |
| Other Operating Income | 59,136 | 468.216% | 10,407 | (7,604) | (19,088) | 22,972 |
| Total Operating Income | 171,438 | 14.455% | 149,786 | 127,994 | 118,607 | 166,517 |
| Net Insurance Claims Incurred & Movement in Policyholders' Liabilities | 0 | -- | 0 | 0 | 0 | 0 |
| Net Operating Income | 171,438 | 14.455% | 149,786 | 127,994 | 118,607 | 166,517 |
| Operating Expenses | (23,016) | -4.178% | (24,020) | (24,517) | (25,464) | (26,603) |
| Impairment Losses on Loans & Advances | (13,146) | -49.821% | (26,198) | (7,849) | (10,940) | (69,125) |
| Other Impairment Losses | 0 | -- | 0 | 0 | 0 | 0 |
| Operating Profit / (Loss) | 135,276 | 35.862% | 99,569 | 95,628 | 82,203 | 70,790 |
| Change in FV & Impairment on Inv. Prop. | 0 | -- | 0 | 0 | 0 | 0 |
| Change in FV & Impairment on Others | (9,150) | -- | 0 | 0 | 0 | 0 |
| Profit / (Loss) on Disposal | 0 | -- | 0 | 0 | 0 | 0 |
| Other Non-operating Items | 0 | -- | 0 | 0 | 0 | 0 |
| Share of Results of Asso. & JCEs | 0 | -- | 0 | 0 | 0 | 0 |
| Profit / (Loss) before Taxation | 126,126 | 26.672% | 99,569 | 95,628 | 82,203 | 70,790 |
| Taxation | (29,793) | 27.434% | (23,379) | (23,199) | (20,246) | (16,909) |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- |
| Non-controlling Interests | (4,619) | -59.388% | (11,375) | (11,729) | (19,878) | (12,785) |
| Others | -- | -- | -- | -- | -- | -- |
| Profit / (Loss) Attributable to Shareholders | 91,714 | 41.501% | 64,815 | 60,700 | 42,079 | 41,096 |
| 2024/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | |
| Depreciation & Amortisation | 4,367 | 28.177% | 3,407 | 3,532 | 2,996 | 4,740 |
| Directors' Emoluments | -- | -- | -- | -- | -- | -- |
| 2024/12 - Final | %Chg (Compare to Final) | 2023/12 | 2022/12 | 2021/12 | 2020/12 | |
| Auditor's Opinion Status | Unqualified | -- | Unqualified | Unqualified | Unqualified | Unqualified |
| 2024/12 - Final | %Chg (Compare to Final) | 2023/12 | 2022/12 | 2021/12 | 2020/12 | |
| EPS (cts) | 13.000 | 30.000% | 10.000 | 9.000 | 6.000 | 6.000 |
| DPS (cts) | 5.000 | -- | 5.000 | 5.000 | 5.000 | 5.000 |
| Dividend Payout Ratio (%) | 38.462% | -- | 50.000% | 55.556% | 83.333% | 83.333% |
| Cash flow per share ($) | 0.294 | -- | 0.099 | 0.316 | 0.064 | 0.101 |
| NBV per share ($) | 1.794 | -- | 1.705 | 1.659 | 1.620 | 1.599 |
| Remarks: | Real time quote last updated: 28/10/2025 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 43,014 |
| %Change | 29.361% |
| EPS / (LPS) | RMB 0.060 |
| NBV Per Share (¥) | RMB 1.807 |